• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Mechanisms by which Eculizumab (Soliris) may benefit COVID-19 patients with respiratory distress syndrome

June 19, 2020COVID-19, Vizit Graphs
Mechanisms by which Eculizumab (Soliris) may benefit COVID-19 patients with respiratory distress syndromeEftychia Lekka2020-08-03T14:03:26+00:00
Mechanisms by which Eculizumab (Soliris) may benefit COVID-19 patients with respiratory distress syndrome

Eculizumab is a biologic therapy, a complement C5 inhibitor, and has recently shown promise in COVID-19. The graph provides an important step towards elucidating the MoA of this drug in COVID-19.

Explore the live graph.

Tags: ACE, ACUTE RESPIRATORY DISTRESS SYNDROME, ALTERNATIVE, C5, COMPLEMENT ACTIVATION, COMPLEMENT C3, COMPLEMENT PATHWAY, COVID-19, ECULIZUMAB, GLOMERULAR FILTRATION RATE, GRAFT SURVIVAL, HEMOGLOBIN, HEMOLYSIS, IL6, IMMUNITY, PLATELET COUNT, SARS-COV-2

Post navigation

← Mechanistic analysis of Atorvastatin
Mechanistic analysis of Acalabrutinib (Calquence) →

Vizit Graphs Tag Cloud

CELL DIFFERENTIATION ESCHERICHIA COLI INFLAMMATION CASP3 COVID-19 ACE ACE2 TNF ALZHEIMER'S DISEASE IMMUNE RESPONSE CELL PROLIFERATION TMPRSS2 COGNITION RAS HELICOBACTER PYLORI AGING APOPTOTIC PROCESS INSULIN IMMUNITY IFNG IL2 PSEUDOMONAS AERUGINOSA METFORMIN NFKB1 INFLAMMATORY RESPONSE ANGIOTENSIN II INTERFERON CANCER IL6 IL10 STAPHYLOCOCCUS AUREUS LACTATE DEHYDROGENASE SARS-COV-2 NEUTROPHILS COAGULATION LISTERIA MONOCYTOGENES ALBUMIN CANDIDA ALBICANS IL1B CD4 PD-1 PARKINSON DISEASE MYALGIA AUTOPHAGY RHEUMATOID ARTHRITIS

© 2021 Biovista Vizit All Rights Reserved.